Paradigm Spine's Coflex interlaminar technology will now be covered by Medicare in Alabama, Georgia and Tennessee, according to International Business Times. Paradigm received a favorable Medicare determination by Cahaba Government Benefit Administrators, a contractor with the Centers for Medicare and Medicaid Services, for the post-decompression and motion preserving interlaminar stabilization device.
The Coflex received FDA PMA approval at the end of 2012, and reached a favorable Medicare determination for use as a non-fusion alternative for symptomatic spinal stenosis.
More Articles on Devices:
Drug-Device Combination Market to Reach $30.5B by 2017
InspireMD Names Alan Milinazzo President, CEO
Soft Tissue Regeneration Receives Market Approval for Rotator Cuff Repair Device
The Coflex received FDA PMA approval at the end of 2012, and reached a favorable Medicare determination for use as a non-fusion alternative for symptomatic spinal stenosis.
More Articles on Devices:
Drug-Device Combination Market to Reach $30.5B by 2017
InspireMD Names Alan Milinazzo President, CEO
Soft Tissue Regeneration Receives Market Approval for Rotator Cuff Repair Device